State Legislation | Association for Accessible Medicines
AAM All Access Podcast - AAM CEO Dan Leonard convenes industry and policy experts to explore why the Inflation Reduction Act (f/k/a Build Back Better) reduces generic and biosimilar competition.

State Legislation


Please see below for shareable resources, press releases and other content relating to this issue. You can also use the search bar in the header of our website to search for specific keywords across all content on the site.

PDFOct 12, 2021Ericka Nguyen
AAM 2021 U.S. Generic and Biosimilar Medicines Savings Report
Download |
Press Release Sep 21, 2021 Rachel Schwartz
Study Finds U.S. Generic and Biosimilar Savings Totaled A Record $338 Billion in 2020

Association for Accessible Medicines


Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.